Aptamer Group has announced the launch of its biomarker discovery service, offering researchers in pharmaceutical, biotechnology, and diagnostic development an innovative approach to identify and validate new disease markers.
CN Bio, a provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, has announced the expansion of its Contract Research Services (CRS) with new PhysioMimix computational modelling tools.
Aptamer Group, a developer of next-generation synthetic binders delivering innovation to the life science industry, has announced the launch of its biomarker discovery service.
Bio-Rad Laboratories, a specialist in life science research and clinical diagnostics products, has announced the introduction of a new range of StarBright Dyes, designed to provide greater choice for spectral flow cytometry in immunology research.
Scenic Biotech, a pioneer in modifier therapies for severe diseases, has announced a license and research agreement with Alnylam Pharmaceuticals to leverage Scenic's Cell-Seq platform for discovering novel targets for RNAi therapeutics.
Thermo Fisher Scientific has introduced the Applied Biosystems MagMAX HMW DNA Kit, providing a streamlined manual and automated extraction workflow to enable the reproducible isolation of High Molecular Weight DNA suitable for long-read sequencing.
Centauri, an immunotherapy company, announced that CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) has provided an additional $5.1M in funding for the development of their lead compound.
Kling Bio has entered into a collaboration and license option agreement with Sanofi for the discovery of antibodies and epitopes using its B cell immortalisation and screening platform, Kling-Select.
OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, has been named a Gold Winner in the 2025 Merit Awards for Business in the Research and Development category.
Shift Bioscience (Shift), a company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, has announced the results of a study detailing an improved approach to ranking virtual cell models for gene discovery.
